Search

everythinglearnresearchcommunity

for

Search:↓

Genetic differences affect COVID-19 severity and treatment development.

Human leukocytes and beard hair follicle cells have internal daily clocks, and PER1 and PER3 genes may indicate individual circadian rhythms.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Cosmetics and procedures can cause eye issues, from mild discomfort to serious conditions, due to allergies, toxins, or poor care.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Losartan can cause temporary loss of taste.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Finasteride shows promise for female hair loss, but more research needed.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Oral zinc sulphate reduces dark hair color in mice.